<DOC>
	<DOC>NCT00971399</DOC>
	<brief_summary>The purpose of this study is: 1. To compare prophylactic effect of ondansetron versus ramosetron on radiotherapy induced nausea and vomiting in the treatment of gastrointestinal cancer. 2. To verify an improvement of 20% in complete response rate in term of radiotherapy induced nausea and vomiting (from 60% with ondansetron to 80% with ramosetron).</brief_summary>
	<brief_title>Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Ramosetron</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>AJCC 13 staged gastrointestinal cancer patient patient undergoing radiotherapy as treatment age 20 yr and higher ECOG 02 age &lt; 20 ECOG 34 patient experiencing nausea or vomiting prior to accrual patient under antiemetic medication patient under steroid medication (topical or inhalant steroid application are exceptional) patient under opioid medication</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>